SecBot SecBot
SECBOTREPLAY Home › Report › RYTM

RYTM · Rhythm Pharmaceuticals announced the appointment of Kimberly Popovits…

RHYTHM PHARMACEUTICALS, INC. · 8-K filed Apr 3, 2026 at 15:06 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 3, 2026 at 15:06 ET

Rhythm Pharmaceuticals announced the appointment of Kimberly Popovits to its Board of Directors and the resignation of Edward T. Mathers, effective April 1, 2026. The changes reflect a routine board transition, with Popovits bringing extensive biopharma leadership experience and Mathers departing amicably after years of service.

  • Kimberly J. Popovits appointed to the Board of Directors effective April 1, 2026, as a Class II director
  • Edward T. Mathers resigned from the Board effective April 1, 2026, with no disagreement with the company
  • Popovits has prior leadership experience as CEO of Genomic Health and senior roles at Genentech
  • No financial terms, compensation changes, or strategic shifts were disclosed in connection with the board changes

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access